Utah Approved Pilot for AI-Driven Acne Prescriptions
The pilot program allows an AI to assess patients for acne treatment under the supervision of a licensed clinician.
Updated on Oct. 5, 2026 in Artificial Intelligence
Live Poll
Do you trust artificial intelligence to issue medical prescriptions without direct human review?
Utah regulators have announced a pilot program that enables an AI product to evaluate patients and generate drug prescriptions for acne. The initiative operates within the state's AI sandbox, a regulatory framework that waives certain rules for emerging technology testing.
Why it matters
The program represents a significant expansion of Utah's AI sandbox initiative, which aims to foster innovation by allowing companies to test new clinical AI tools under state supervision. It signals a move toward evaluating how automated diagnostic systems can safely integrate into existing healthcare workflows.
The Nolla Health service utilizes structured patient intake processes combined with photo analysis to evaluate skin conditions. While the system currently generates prescription recommendations, it requires sign-off from a licensed clinician before any medication is issued.
The players
Nolla Health
A health-tech startup that focuses on developing AI-powered diagnostic and treatment tools for skin conditions.
Utah Office of Artificial Intelligence Policy
The state agency responsible for overseeing the AI sandbox program and waiving regulatory barriers for tech testing.
The details
The Nolla Health system functions by parsing patient-provided information and images to determine the clinical appropriateness of acne medication. Under the Utah Office of Artificial Intelligence Policy (OAIP) — a state office created to oversee the testing of new AI products — regulatory requirements are waived for participants. The pilot ensures safety by keeping a human clinician in the loop, who must manually verify and sign off on all prescriptions generated by the software.
Timeline
2025: Nolla Health raised $4.5 million from investors.
October 5, 2026: Utah regulators announced the AI pilot program.
The Tech Race
This pilot program fits within the broader national effort to establish regulatory frameworks for AI in medicine. It marks a shift from laboratory research to state-sanctioned clinical trials of diagnostic software.
Residents of Utah experiencing acne may soon have access to this AI-assisted evaluation process as the pilot rolls out. Participants should note that the current model requires a clinician to review and approve all prescriptions issued by the platform.
The takeaway
Nolla Health plans to eventually expand its diagnostic capabilities to cover a wider range of medical conditions beyond acne. Watch for future updates from the Office of Artificial Intelligence Policy on whether the pilot progresses to allow prescription issuance without direct clinician review.
Further reading
For more on the state's role in testing emerging software, see the Artificial Intelligence section.
Live Poll
Do you trust artificial intelligence to issue medical prescriptions without direct human review?
